InsidersTradesSigma
동성제약 Stock: price and directors' dealings · South Korea · DART (FSS)
Follow the 동성제약 stock price and the full insider trade history of the company, a listed issuer based in South Korea. Shares trade on KR KR, under the supervision of DART (FSS). Operating in the Health Care sector, 동성제약 has published 6 public disclosures. Market capitalisation: €171.5bn. The latest transaction was reported on 15 April 2026 (Purchase). Among the most active insiders: 유암코제약산업제1호기업재무안정사모투자. Every trade is openly available.
6
Insider Decl.
n/a
Thresholds
€96m
5 ops.
Buy Volume
€4m
1 ops.
Sell Volume
12Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 24,726 of 28,169 companies
24.2
score / 100
Value14
Quality34
FCF yld-9.7%
Earn yld-18%
EV/EBITDA·
ROE2.9%
Gross mgn43%
Net mgn-30%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 15 April 2026
Declarations6 total
31,500,000 shares@ ₩1,000.000.017% mcap100.0% of flowShareKRXDART:20260415000145
8,500,000 shares@ ₩1,000.000.0047% mcap100.0% of flowShareKRXDART:20260415000150
50,000,000 sharesKRXDART:20260415000133
70,000,000 sharesKRXDART:20260406003017
6 of 6 declarations
About 동성제약
Dong Sung Pharmaceutical is a South Korean company specializing in the health and pharmaceutical sector. It is listed on the XKRX market.